India to Philippines: Pyrazinamide Export Trade Route
India has recorded 62 verified shipments of Pyrazinamide exported to Philippines, representing a combined trade value of $7.4M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $119.1K USD. The leading Indian exporter is LUPIN LIMITED, which accounts for 89% of total export value with 42 shipments worth $6.6M USD. On the buying side, DEPARTMENT OF HEALTH is the largest importer in Philippines with $2.4M USD in purchases. The top 3 suppliers — LUPIN LIMITED, OMNICALS PHARMA PRIVATE LIMITED, MANEESH PHARMACEUTICALS LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Philippines Pyrazinamide corridor is one of India's established pharmaceutical export routes, with 62 shipments documented worth a combined $7.4M USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's pyrazinamide manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $119.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with pyrazinamide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 18.1%, placing it at rank #13 among India's top pyrazinamide export destinations globally.
On the import side, key buyers of Indian pyrazinamide in Philippines include DEPARTMENT OF HEALTH, LUPIN PHILIPPINES INC, LUPIN PHILIPPINES INC. and 10 others. DEPARTMENT OF HEALTH is the single largest importer with 5 shipments valued at $2.4M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#13
- Annual growth+18.1%
- Demand growth+15.6%
- Regulatory ease74/100
Top 10 Indian Pyrazinamide Exporters to Philippines
Showing top 10 of 7 Indian suppliers exporting Pyrazinamide to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED Avg $156.1K per shipment | 42 | $6.6M | 88.8% |
| 2 | OMNICALS PHARMA PRIVATE LIMITED Avg $31.8K per shipment | 8 | $254.8K | 3.5% |
| 3 | MANEESH PHARMACEUTICALS LIMITED Avg $34.8K per shipment | 6 | $208.9K | 2.8% |
| 4 | MICRO LABS LIMITED Avg $97.7K per shipment | 2 | $195.4K | 2.6% |
| 5 | MANEESH PHARMACEUTICALS LIMITED Avg $74.9K per shipment | 1 | $74.9K | 1.0% |
| 6 | MANEESH PHARMACEUTICALS LTD Avg $37.4K per shipment | 2 | $74.9K | 1.0% |
| 7 | FLAMINGO PHARMACEUTICALS LIMITED Avg $18.1K per shipment | 1 | $18.1K | 0.2% |
This table shows the top 10 of 7 Indian companies exporting pyrazinamide to Philippines, ranked by total trade value. The listed exporters are: LUPIN LIMITED, OMNICALS PHARMA PRIVATE LIMITED, MANEESH PHARMACEUTICALS LIMITED , MICRO LABS LIMITED , MANEESH PHARMACEUTICALS LIMITED, MANEESH PHARMACEUTICALS LTD, FLAMINGO PHARMACEUTICALS LIMITED . LUPIN LIMITED is the dominant supplier with 42 shipments worth $6.6M USD, giving it a 89% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Pyrazinamide Importers in Philippines
Showing top 10 of 13 known buyers in Philippines receiving Pyrazinamide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pyrazinamide in Philippines include DEPARTMENT OF HEALTH, LUPIN PHILIPPINES INC, LUPIN PHILIPPINES INC., LUPIN PHILIPPINES, INC., LUPIN PHILIPPINES INC.., among 13 total buyers. The largest importer is DEPARTMENT OF HEALTH, accounting for $2.4M USD across 5 shipments — representing 32% of all pyrazinamide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DEPARTMENT OF HEALTH | 5 | $2.4M | 32.0% |
| 2 | LUPIN PHILIPPINES INC | 17 | $2.0M | 27.7% |
| 3 | LUPIN PHILIPPINES INC. | 11 | $1.0M | 13.8% |
| 4 | LUPIN PHILIPPINES, INC. | 4 | $676.8K | 9.2% |
| 5 | LUPIN PHILIPPINES INC.. | 5 | $451.4K | 6.1% |
| 6 | AMBICA INTERNATIONAL CORPORATION | 6 | $208.9K | 2.8% |
| 7 | DEPARTMENT OF HEALTH | 2 | $195.4K | 2.6% |
| 8 | AMBICA INTERNATIONAL CORPORATION | 3 | $149.8K | 2.0% |
| 9 | TO THE ORDER OF METROPOLITAN BANK | 4 | $107.5K | 1.5% |
| 10 | TO THE ORDER OF | 1 | $74.5K | 1.0% |
Showing top 10 of 13 Pyrazinamide importers in Philippines on this route.
Top 10 Pyrazinamide Formulations Imported by Philippines
Showing top 10 of 39 product formulations shipped on the India to Philippines Pyrazinamide route, ranked by trade value
Philippines imports a wide range of pyrazinamide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Rifampicin 150mg+Isoniazide 75mg+ Pyrazinamide 400mg+ Ethambutol 275mg Hydrochloride Tablets USP(7500 BOX, SIZE:24x28T) — accounts for $967.8K USD across 2 shipments. There are 39 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Rifampicin 150mg+Isoniazide 75mg+ Pyrazinamide 400mg+ Ethambutol 275mg Hydrochloride Tablets USP(7500 BOX, SIZE:24x28T) | 2 | $967.8K | 13.1% |
| 2 | QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP | 4 | $962.7K | 13.0% |
| 3 | RIFA150+INH75+PZN400+ETB275 24X28T GDF Rifampicin,Isoniazid,Pyrazinamide and Ethambutol Hydrochloride Tablet USP(7240BOX | 2 | $918.1K | 12.4% |
| 4 | QUADMAX 20X4T (PHILIPPINES) Rifampin 150,Isoniazid 75,Pyrazinamide 400 and Ethambutol HCl 275 mg Tablets USP (QTY: 39 | 3 | $580.3K | 7.9% |
| 5 | Rifampicin 150MG Isoniazid 75MG Pyrazinamide 400MG and Ethambutol Hydrochloride275MG Tablets (7500 BOX, SIZE:24x28T) | 1 | $479.6K | 6.5% |
| 6 | QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN, ISONIAZID, PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP | 1 | $308.3K | 4.2% |
| 7 | QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP. | 1 | $285.4K | 3.9% |
| 8 | QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USPNOS | 3 | $274.7K | 3.7% |
| 9 | QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN, ISONIAZID, PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USPNOS | 3 | $273.8K | 3.7% |
| 10 | QUADMAX 20X4T PHILIPPINES Rifampin 150 Isoniazid 75 Pyrazinamide 400 and Ethambutol HCl 275 mg Tablets USP Antitubercu | 1 | $203.9K | 2.8% |
Showing top 10 of 39 Pyrazinamide formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 16 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's pyrazinamide exports to Philippines are driven primarily by a handful of large-scale manufacturers. LUPIN LIMITED with 42 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LUPIN LIMITED, OMNICALS PHARMA PRIVATE LIMITED, MANEESH PHARMACEUTICALS LIMITED — together account for 95% of total trade value on this route. The average shipment value of $119.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as quadmax 12x14t alu / alu philippines rifampin isoniazid pyrazinamide and ethambutol hydrochloride tablets usp and rifa150+inh75+pzn400+etb275 24x28t gdf rifampicin,isoniazid,pyrazinamide and ethambutol hydrochloride tablet usp(7240box, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DEPARTMENT OF HEALTH is the largest importer with 5 shipments worth $2.4M USD — representing 32% of all pyrazinamide imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $7.4M
- Avg. Shipment
- $119.1K
- Suppliers
- 7
- Buyers
- 13
- Transit (Sea)
- ~27 days
- Annual Growth
- +18.1%
Related Analysis
Other Pyrazinamide Routes
Unlock the Full India to Philippines Pyrazinamide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 62 shipments on this route.
Frequently Asked Questions — India to Philippines Pyrazinamide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pyrazinamide to Philippines?
The leading Indian exporters of Pyrazinamide to Philippines are LUPIN LIMITED, OMNICALS PHARMA PRIVATE LIMITED, MANEESH PHARMACEUTICALS LIMITED . LUPIN LIMITED holds the largest market share at approximately 89% of total trade value on this route.
Q What is the total value of Pyrazinamide exports from India to Philippines?
India exports Pyrazinamide to Philippines worth approximately $7.4M USD across 62 recorded shipments. The average value per shipment is $119.1K USD.
Q Which ports does India use to ship Pyrazinamide to Philippines?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 16 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Philippines for Pyrazinamide?
The average transit time for Pyrazinamide shipments from India to Philippines is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Pyrazinamide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.1% with demand growth tracking at 15.6%. The route is ranked #13 among India's top Pyrazinamide export destinations globally.
Q How many suppliers are active on the India to Philippines Pyrazinamide route?
There are currently 7 active Indian suppliers exporting Pyrazinamide to Philippines. The market is moderately concentrated with LUPIN LIMITED accounting for 89% of total shipment value.
Q Who are the main importers of Pyrazinamide from India in Philippines?
The leading importers of Indian Pyrazinamide in Philippines include DEPARTMENT OF HEALTH, LUPIN PHILIPPINES INC, LUPIN PHILIPPINES INC., LUPIN PHILIPPINES, INC., LUPIN PHILIPPINES INC... DEPARTMENT OF HEALTH is the largest buyer with 5 shipments worth $2.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Pyrazinamide.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 13 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 62 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
62 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists